Marker TherapeuticsMRKR
13F holders, Q3 2025 (September 30)32holders +1
7new positions
7sold out
1famous investor
$0.89avg. 13F price*
At the end of Q3 2025, 32 institutions reported holding Marker Therapeutics Inc. (MRKR) in their 13F filings, up 1 from Q2 2025. 7 opened new positions and 7 sold out. The largest holders were NEA Management Company, LLC ($1.5M), Blue Owl Capital Holdings LP ($495K) and Aisling Capital Management LP ($290K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Marker Therapeutics Inc.
- CUSIP
- 57055L206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $137K |
| Exits | 7 | $424K |
All 13F filers, Q2 2025 → Q3 2025: 286,839 shares bought and 293,939 shares sold, net −7,100 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 32 holders
| NEA Management Company, LLC | 0.08% | No change | 1,625,678 | $1.5M |
| Blue Owl Capital Holdings LP | 0.15% | No change | 554,250 | $495K |
| Aisling Capital Management LP | 0.06% | No change | 325,370 | $290K |
| Vanguard Group Inc. | 0.00% | Add +8.9% | 299,781 | $268K |
| Renaissance Technologies | 0.00% | Add +53.0% | 106,250 | $95K |
| Geode Capital Management, LLC | 0.00% | Add +0.6% | 96,316 | $86K |
| Osaic Holdings, Inc. | 0.00% | Add +314.2% | 81,081 | $74K |
| LPL Financial LLC | 0.00% | Reduce -20.3% | 58,747 | $52K |
| Torrey Growth & Income Advisors | 0.01% | — | 51,984 | $46K |
| Two Sigma Securities, LLC | 0.01% | New | 47,603 | $42K |
| Two Sigma Investments, LP | 0.00% | New | 36,540 | $33K |
| Invst, LLC | 0.00% | Add +23.9% | 29,000 | $26K |
| Virtu Financial LLC | 0.00% | New | 28,329 | $25K |
| XTX Topco Ltd | 0.00% | New | 21,772 | $19K |
| State Street Corp. | 0.00% | No change | 20,948 | $19K |
| Creative Planning | 0.00% | No change | 17,312 | $15K |
| Matrix Asset Advisors Inc. | 0.00% | No change | 15,000 | $13K |
| Northern Trust Corp. | 0.00% | No change | 10,857 | $10K |
| Ashton Thomas Private Wealth, LLC | 0.00% | New | 10,000 | $9K |
| Citigroup Inc. | 0.00% | New | 9,276 | $8K |
| UBS Group AG | 0.00% | Add +262.1% | 5,794 | $5K |
| Bank of America Corp. | 0.00% | Add +0.8% | 1,123 | $1K |
| BlackRock, Inc. | 0.00% | No change | 992 | $885 |
| Morgan Stanley | 0.00% | Add +15.0% | 461 | $412 |
| Wells Fargo & Company | 0.00% | Add +4.3% | 242 | $216 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -88.1% | 203 | $181 |
| Group One Trading LLC | 0.00% | No change | 178 | $159 |
| FMR LLC | 0.00% | New | 150 | $134 |
| Hilltop National Bank | 0.00% | No change | 73 | $65 |
| JPMorgan Chase & Co. | 0.00% | Reduce -89.3% | 23 | $21 |
| BNP Paribas Financial Markets | 0.00% | No change | 23 | $21 |
| Versant Capital Management, Inc | 0.00% | No change | 15 | $13 |
"% of holder's portfolio" is MRKR's weight in each manager's 13F, not the share of Marker Therapeutics Inc. the manager owns.